Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort

BACKGROUND: Patients with systemic lupus erythematosus (SLE) are at risk of developing COVID-19 due to underlying immune abnormalities and regular use of immunosuppressant medications. We aimed to evaluate the presence of SARS-CoV-2 IgG antibodies in patients with SLE with or without previous COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, Amit, Guttmann, Allison, Masson, Mala, Kim, Mimi Y, Haberman, Rebecca H, Castillo, Rochelle, Scher, Jose U, Deonaraine, Kristina K, Engel, Alexis J, Belmont, H Michael, Blazer, Ashira D, Buyon, Jill P, Fernandez-Ruiz, Ruth, Izmirly, Peter M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159192/
https://www.ncbi.nlm.nih.gov/pubmed/34075358
http://dx.doi.org/10.1016/S2665-9913(21)00114-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159192/
https://www.ncbi.nlm.nih.gov/pubmed/34075358
http://dx.doi.org/10.1016/S2665-9913(21)00114-4

Ejemplares similares